Nuclear Factor-κB Decoy Oligodeoxynucleotide Attenuates Cartilage Resorption In Vitro

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Tissue Engineering

Background:

• Cartilage grafts are used in craniofacial reconstruction but are prone to absorption and warping due to inflammation.
• Nuclear factor-κB (NF-κB) signaling is a key mediator of inflammatory responses in wound healing.
• Inhibiting NF-κB may offer a strategy to protect cartilage grafts from inflammatory damage.

Purpose of the Study:

• To investigate the chondroprotective potential of an NF-κB decoy oligodeoxynucleotide (Decoy).
• To assess the safety and efficacy of Decoy in preventing cartilage degradation.
• To explore Decoy as a therapeutic agent for cartilage transplantation.

Main Methods:

• Rabbit nasal septal chondrocytes (rNSChs) were used to determine safe and effective Decoy concentrations.
• Assays for cytotoxicity and proteoglycan (PG) synthesis and turnover were performed.
• Human nasal septal cartilage (hNSC) explants were treated with Decoy to analyze PG turnover and inflammatory markers.

Main Results:

• Decoy did not inhibit PG synthesis or cause cytotoxicity in chondrocytes.
• Decoy at 10 μM significantly inhibited PG degradation in human cartilage explants.
• Decoy treatment prolonged PG half-life by 63% and reduced matrix metalloprotease 3 (MMP-3) levels by 70.7%.

Conclusions:

• NF-κB decoy oligodeoxynucleotides (Decoy) demonstrate significant chondroprotective effects.
• Decoy effectively inhibits inflammation-induced cartilage degradation.
• Decoy represents a promising novel therapeutic agent for enhancing cartilage graft survival in transplantation.